Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 31,219 |
|
|||||
| News | - | ||||||
| Day High | 8.88 | Low High |
|||||
| Day Low | 8.50 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.29 | 3.42% | 8.78 | 10:29:58 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.57 | 8.50 | 8.88 | 8.49 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 546 | 31,219 | US$ 8.67 | US$ 270,766 | - | 4.004 - 40.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 10:29:57 | 1 | US$ 8.785 | USD |
Outlook Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 112.82M | 13.01M | - | 0 | -58.98M | -4.53 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Outlook Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.22 | 9.2899 | 8.13 | 8.70 | 179,880 | 0.56 | 6.81% |
| 1 Month | 9.55 | 9.98 | 7.80 | 8.70 | 250,902 | -0.77 | -8.06% |
| 3 Months | 8.636 | 12.8499 | 5.0401 | 8.53 | 1,309,016 | 0.144 | 1.67% |
| 6 Months | 6.80 | 12.8499 | 5.0401 | 8.65 | 1,984,327 | 1.98 | 29.12% |
| 1 Year | 22.60 | 40.60 | 4.004 | 10.73 | 4,036,364 | -13.82 | -61.15% |
| 3 Years | 47.94 | 65.40 | 4.004 | 20.11 | 2,124,339 | -39.16 | -81.69% |
| 5 Years | 25.20 | 85.20 | 4.004 | 26.57 | 2,136,505 | -16.42 | -65.16% |
Outlook Therapeutics Description
| Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |
